Company Filing History:
4 out of 3,540 
3 out of 975 
3 out of 89 
Years Active: 2018-2021
Title: Sandeep S Dave: Innovator in Lymphoma Research
Introduction
Sandeep S Dave is a prominent inventor based in Chapel Hill, NC (US), known for his significant contributions to the field of lymphoma research. With a total of six patents to his name, he has made remarkable strides in developing methods for identifying and predicting survival in lymphoma patients.
Latest Patents
One of his latest patents is a survival predictor for diffuse large B cell lymphoma (DLBCL). This invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients. Another notable patent involves methods for identifying, diagnosing, and predicting survival of lymphomas. This invention utilizes gene expression data to enhance the accuracy of identifying and diagnosing lymphoproliferative disorders. Furthermore, it introduces the Lymph Dx microarray, a novel tool for obtaining gene expression data from lymphoma samples. These advancements are crucial for determining the identity of specific lymphomas and predicting survival outcomes for patients.
Career Highlights
Sandeep S Dave has had a distinguished career, working with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Arizona. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Louis M Staudt and Erlend B Smeland. Their collaborative efforts have further advanced the understanding and treatment of lymphomas.
Conclusion
Sandeep S Dave's innovative work in lymphoma research has led to significant advancements in patient care and treatment strategies. His contributions continue to impact the field positively, making him a notable figure in medical research.